C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism

Abstract

Get full access to this article

View all access options for this article.

References

Dai

ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. Eur J Prev Cardiol. Epub ahead of print 28 April 2020. DOI: 10.1177/2047487320922370.

Cavalli-Sforza

Menozzi

Piazza

The history and geography of human genes. Princeton, NJ: Princeton University Press, 1994.

Delanghe

Speeckaert

de Buyzere

ML.

COVID-19 infections are also affected by human ACE1 D/I polymorphism. Clin Chem Lab Med. Epub ahead of print 14 April 2020. DOI: 10.1515/cclm-2020-0425.

Delanghe

Speeckaert

MM.

Complement C3 and its polymorphism: biological and clinical consequences. Pathology 2014; 46: 1–10.

Henry

Oriol

Samuelsson

Lewis histo-blood group system and associated secretory phenotypes. Vox Sang 1995; 69: 166–182.